Willis Towers Watson (WLTW) M&A Announcement summary

Deal rationale and strategic fit

• Expands reach in the U.S. middle market and high-growth specialties such as technology, fintech, and life sciences.

• Broadens producer base with over 120 new producers and accelerates performance.

• Integrates advanced technology, including proprietary AI and digital platforms, enhancing client and broker experience.

• Complements and aligns with existing business segments, supporting growth in broking and high-margin areas.

• Emphasizes cultural alignment, innovation, and client service.

Financial terms and conditions

• Total consideration up to $1.3 billion: $1.05 billion upfront ($900 million cash, $150 million equity), up to $250 million contingent on performance.

• Additional $150 million in equity possible if above-target revenue growth is achieved.

• $100 million in equity-based retention incentives for employees through 2031.

• Upfront cash funded with new long-term debt; expected to maintain current credit ratings.

• Total consideration represents roughly 12x estimated 2026 pro forma Adjusted EBITDA, including synergies.

Synergies and expected cost savings

• Estimated $35 million in run-rate cost synergies by end of 2028, mainly from technology-driven efficiencies and overhead optimization.

• Overhead efficiencies through consolidation of back-office and corporate functions.

• Integration costs estimated at $125 million over three years, with $100 million as cash costs.

• Synergy estimates include efficiency gains from integrating technology across the combined business.

• Transaction expenses of $25 million and non-cash asset write-off costs of $30 million over three years.